FCM
PFE icon

Family Capital Management’s Pfizer PFE Stock Holding History

Family Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$790K Buy
28,119
+946
+3% +$25.2K 0.35% 48
2025
Q4 		$677K Sell
27,173
-2,812
-9% -$70.9K 0.3% 58
2025
Q3 		$764K Sell
29,985
-625
-2% -$15.4K 0.36% 51
2025
Q2 		$742K Buy
+30,610
New +$714K 0.39% 47

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Family Capital Management's PFE Position: Q1 2026 in Review

Family Capital Management increased its Pfizer (PFE) stake by 3.5% in Q1 2026, buying an estimated $25.2K and bringing the position to 28,119 shares worth $790K. The position accounts for 0.35% of the portfolio, ranked #48.

Family Capital Management first reported a position in PFE in Q2 2025 and has held it in 4 quarters since. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Family Capital Management held 28,119 shares of Pfizer worth $790K as of Q1 2026.
  • Family Capital Management bought 946 Pfizer shares in Q1 2026, an estimated $25.2K.
  • Pfizer made up 0.35% of Family Capital Management's portfolio in Q1 2026, its #48 holding.
  • Family Capital Management first reported a position in Pfizer in Q2 2025 and has held it in 4 quarters since.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Family Capital Management's 13F filing for Q1 2026, filed 23 Apr 2026.